WINCAP FINANCIAL LLC

Position in PFE — Pfizer Inc

CIK 2064588 BOSTON, MA

Position in PFE

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,119,623

-$73,917 QoQ

Shares Held

46,496

+9.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.14%

of 13F equity value

Holder Rank

#1,267

of 2,821 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WINCAP FINANCIAL LLC holds $8,253,715 across 6 Drug Manufacturers - General names. PFE ranks #4 (13.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	10,261	$2,582,078
2	MRK	Merck & Co., Inc.	12,130	$1,558,705
3	BMY	Bristol Myers Squibb Co	23,756	$1,368,820
4	PFE	Pfizer Inc This page	46,496	$1,119,623
5	AMGN	Amgen Inc	2,444	$885,021
6	GILD	Gilead Sciences, Inc.	5,853	$739,468

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,119,623	46,496	+9.4%	Shares	Sole	2026-07-09
2026-03-31	$1,193,540	42,505	+13.1%	Shares	Sole	2026-04-09
2025-12-31	$935,866	37,585	-14.9%	Shares	Sole	2026-01-14
2025-09-30	$1,124,992	44,152	+4.4%	Shares	Sole	2025-11-07
2025-06-30	$1,025,085	42,289	+6.8%	Shares	Sole	2025-08-01
2025-03-31	$1,003,210	39,590	+15.7%	Shares	Sole	2025-05-07
2024-12-31	$907,830	34,219	—	Shares	Sole	2025-05-07
No filing history on record for this holder in this stock.